Roch unit 8 UNIT 8 DISCUSSION Instructions: For each of the learning objectives, provide an analysis of how the course supported each

Roch unit 8

UNIT 8 DISCUSSION

Instructions:

For each of the learning objectives, provide an analysis of how the course supported each objective.

1. Discriminate among the mechanisms of action for the major classes of drugs/medications

2. Critique evidence that supports proposed pharmacotherapeutic protocols for appropriateness of application across the lifespan

3. Integrate the teaching-learning needs of clients across the lifespan when proposing pharmacotherapies

4. Propose prescriptive therapies for selected clients evaluating safety factors while utilizing knowledge of how current health status, age, gender, culture, genetic factors, ethical concerns and prescriptive authority impact decision making

Explain how the material learned in this course, based upon the objectives, will be applicable to professional application.

Provide evidence (citations and references) to support your statements and opinions.

All references and citations should in APA format.

This Unit 8 discussion post does not require any peer responses and must be submitted by Tuesday at 11:59am (noon) of week 8.

Estimated time to complete: 1 hour

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

  Therapeutic Relationship Case

  Therapeutic Relationship Case  Cases J.J is a nurse practitioner who works in a primary care facility. He believes that one of the most important aspects of his work is to foster a therapeutic relationship with his clients. He is using effective communication techniques. Many of his clients have altered

15 S 21st St., Suite 205 Fargo, ND 58103

15 S 21st St., Suite 205 Fargo, ND 58103     BASIC ASSURANCES SYSTEM     Procedure Title: Basic Assurances System  Procedure Type: Service Operations  Number: 10 Original Date Issued: 03/11/2022  Effective Date: 03/11/2022  Approved By: Gibson W. Jerue, CEO  Approved Date: 03/11/2022  Revision Date(s):   Policy Reference: Basic Assurances System    Disability